<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">Colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) is a major cause of morbidity and mortality in developed countries </plain></SENT>
<SENT sid="1" pm="."><plain>Despite operative advances and the widespread adoption of combined-modality treatment, the 5-year survival rarely exceeds 60% </plain></SENT>
<SENT sid="2" pm="."><plain>Improving our understanding of the biological processes involved in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> development and progression will help generate new diagnostic and prognostic approaches </plain></SENT>
<SENT sid="3" pm="."><plain>Previous studies have identified altered metabolism as a common feature in <z:e sem="disease" ids="C0596263" disease_type="Neoplastic Process" abbrv="">carcinogenesis</z:e>, and quantitative measurement of this altered activity (metabonomics/metabolomics) has the potential to generate novel metabolite-based biomarkers for <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> diagnosis, staging and prognostication </plain></SENT>
<SENT sid="4" pm="."><plain>In the present study we applied high-resolution magic angle <z:mp ids='MP_0001411'>spinning</z:mp> nuclear magnetic resonance (HR-MAS NMR) spectroscopy to analyze metabolites in intact <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> samples (n = 83) and samples of adjacent mucosa (n = 87) obtained from 26 patients undergoing surgical resection for <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>Orthogonal partial least-squares discriminant analysis (OPLS-<z:mp ids='MP_0000273'>DA</z:mp>) of metabolic profiles identified marked biochemical differences between <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> tissue and adjacent mucosa (R(2) = 0.72; Q(2) = 0.45; AUC = 0.91) </plain></SENT>
<SENT sid="6" pm="."><plain><z:chebi fb="5" ids="15891">Taurine</z:chebi>, isoglutamine, <z:chebi fb="3" ids="15354">choline</z:chebi>, <z:chebi fb="4" ids="24996">lactate</z:chebi>, phenylalanine, tyrosine (increased concentrations in <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> tissue) together with <z:chebi fb="23" ids="18059">lipids</z:chebi> and <z:chebi fb="4" ids="17855">triglycerides</z:chebi> (decreased concentrations in <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> tissue) were the most discriminant metabolites between the two groups in the model </plain></SENT>
<SENT sid="7" pm="."><plain>In addition, <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> tissue metabolic profiles were able to distinguish between <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> of different T- and N-stages according to TNM classification </plain></SENT>
<SENT sid="8" pm="."><plain>Moreover, we found that <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e>-adjacent mucosa (10 cm from the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> margin) harbors unique metabolic field changes that distinguish <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> according to T- and N-stage with higher predictive capability than <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> tissue itself and are accurately predictive of 5-year survival (AUC = 0.88), offering a highly novel means of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> classification and prognostication in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> </plain></SENT>
</text></document>